REGENXBIO Inc. short interest in 2026
In 2026, REGENXBIO Inc.'s disclosed short interest ran from 10.12% of shares outstanding on 15 Jan 2026 to 12.01% on 15 Sep 2026, a change of +1.89 percentage points. The year's high was 20.27% on 30 Jun 2026 and its low 9.63% on 30 Jan 2026, averaging 13.38% across 17 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 12.63 days on 15 Apr 2026. Full history: REGENXBIO Inc..
Cite this page
By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2026 in figures
- Start of year
- 10.12% (15 Jan 2026)
- End of year
- 12.01% (15 Sep 2026)
- Change
- +1.89 pp
- High
- 20.27% (30 Jun 2026)
- Low
- 9.63% (30 Jan 2026)
- Average
- 13.38%
- Highest days to cover
- 12.63 (15 Apr 2026)
- SEC filings marked
- 6
Every report in 2026
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2026 | 10.12% | 6.89 | |
| 30 Jan 2026 | 9.63% | 3.63 | |
| 13 Feb 2026 | 11.85% | 5.58 | |
| 27 Feb 2026 | 12.37% | 9.05 | |
| 13 Mar 2026 | 12.53% | 5.70 | 10-K filed, results (8-K) |
| 31 Mar 2026 | 13.00% | 8.08 | |
| 15 Apr 2026 | 13.45% | 12.63 | |
| 30 Apr 2026 | 12.97% | 12.13 | |
| 15 May 2026 | 13.83% | 3.19 | 10-Q filed, results (8-K) |
| 29 May 2026 | 16.05% | 4.50 | |
| 15 Jun 2026 | 17.95% | 6.96 | |
| 30 Jun 2026 | 20.27% | 3.19 | |
| 15 Jul 2026 | 16.71% | 3.29 | |
| 31 Jul 2026 | 10.90% | 3.79 | |
| 14 Aug 2026 | 12.42% | 7.77 | 10-Q filed, results (8-K) |
| 31 Aug 2026 | 11.36% | 4.87 | |
| 15 Sep 2026 | 12.01% | 7.66 |
See also: REGENXBIO Inc.'s full history · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.